SCHEMBL20127435

SCHEMBL20127435

c1ccc2c(-c3c4ccccc4c(-c4ccc5ccc6ccccc6c5c4)c4ccccc34)c3oc4ccccc4c3cc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
HSD17B10 Q99714 4/20 0.44
CYP1B1 Q16678 2/20 0.44
HIF1A Q16665 1/20 0.44
ALOX5 P09917 2/20 0.39
AHR P35869 1/20 0.38
KDM4E B2RXH2 5/20 0.35
TDP1 Q9NUW8 3/20 0.35
HPGD P15428 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
GLA P06280 2/20 0.35
MAPT P10636 2/20 0.35
TSHR P16473 2/20 0.35
HTT P42858 1/20 0.35
SOS1 Q07889 1/20 0.35
HNF4A P41235 1/20 0.35
GAA P10253 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2A6 P11509 1/20 0.33
NPC1 O15118 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127434 0.94 CYP1B1 (0.41) ALDH1A1HSD17B10CYP1B1HIF1AALOX5
SCHEMBL20127642 0.92 AHR (0.40) ALDH1A1HSD17B10CYP1B1HIF1AALOX5
SCHEMBL20127453 0.90 MAPT (0.41) ALDH1A1HSD17B10ALOX5AHRKDM4E
SCHEMBL20127432 0.90 ALOX5 (0.40) ALDH1A1ALOX5AHRKDM4ETDP1
SCHEMBL10122559 0.90 GPR84 (0.40) ALDH1A1HSD17B10CYP1B1HIF1AALOX5
SCHEMBL20127460 0.89 GPR84 (0.39) ALDH1A1HSD17B10CYP1B1HIF1AALOX5
SCHEMBL20127445 0.88 ALDH1A1 (0.46) ALDH1A1HSD17B10CYP1B1HIF1AAHR
SCHEMBL20127634 0.87 CYP1B1 (0.39) ALDH1A1HSD17B10CYP1B1HIF1AALOX5
SCHEMBL17931999 0.87 AHR (0.41) ALDH1A1ALOX5AHRKDM4EHPGD
SCHEMBL10122689 0.87 AHR (0.47) ALDH1A1HSD17B10CYP1B1HIF1AALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 ALDH1A1 476/4885HSD17B10 2025/4885CYP1B1 341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.